Anti-PERP/ KCP1/ KRTCAP1 monoclonal antibody

Anti-PERP/ KCP1/ KRTCAP1 antibody for FACS & in-vivo assay

Target products collectionGo to PERP/PERP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1360-Ab-1/ GM-Tg-hg-MP1360-Ab-2Anti-Human PERP monoclonal antibodyHuman
GM-Tg-rg-MP1360-Ab-1/ GM-Tg-rg-MP1360-Ab-2Anti-Rat PERP monoclonal antibodyRat
GM-Tg-mg-MP1360-Ab-1/ GM-Tg-mg-MP1360-Ab-2Anti-Mouse PERP monoclonal antibodyMouse
GM-Tg-cynog-MP1360-Ab-1/ GM-Tg-cynog-MP1360-Ab-2Anti-Cynomolgus/ Rhesus macaque PERP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1360-Ab-1/ GM-Tg-felg-MP1360-Ab-2Anti-Feline PERP monoclonal antibodyFeline
GM-Tg-cang-MP1360-Ab-1/ GM-Tg-cang-MP1360-Ab-2Anti-Canine PERP monoclonal antibodyCanine
GM-Tg-bovg-MP1360-Ab-1/ GM-Tg-bovg-MP1360-Ab-2Anti-Bovine PERP monoclonal antibodyBovine
GM-Tg-equg-MP1360-Ab-1/ GM-Tg-equg-MP1360-Ab-2Anti-Equine PERP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1360-Ab-1/ GM-Tg-hg-MP1360-Ab-2; GM-Tg-rg-MP1360-Ab-1/ GM-Tg-rg-MP1360-Ab-2;
GM-Tg-mg-MP1360-Ab-1/ GM-Tg-mg-MP1360-Ab-2; GM-Tg-cynog-MP1360-Ab-1/ GM-Tg-cynog-MP1360-Ab-2;
GM-Tg-felg-MP1360-Ab-1/ GM-Tg-felg-MP1360-Ab-2; GM-Tg-cang-MP1360-Ab-1/ GM-Tg-cang-MP1360-Ab-2;
GM-Tg-bovg-MP1360-Ab-1/ GM-Tg-bovg-MP1360-Ab-2; GM-Tg-equg-MP1360-Ab-1/ GM-Tg-equg-MP1360-Ab-2
Products NameAnti-PERP monoclonal antibody
Formatmab
Target NamePERP
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PERP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PERP/ KCP1/ KRTCAP1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003774human PERP Lentivirus plasmid
    ORF Viral VectorvGMLP003774human PERP Lentivirus particle


    Target information

    Target IDGM-MP1360
    Target NamePERP
    Gene ID64065,64058,292949,703890,476218,101083938,509485,100067837
    Gene Symbol and Synonyms1110017A08Rik,dJ496H19.1,EKVP7,KCP1,KRTCAP1,OLMS2,PERP,PIGPC1,THW
    Uniprot AccessionQ96FX8
    Uniprot Entry NamePERP_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000112378
    Target ClassificationN/A

    The target: PERP, gene name: PERP, also named as KCP1, KRTCAP1, PIGPC1, THW, dJ496H19.1. Involved in activation of cysteine-type endopeptidase activity. Predicted to be located in plasma membrane. Predicted to be active in cell-cell junction. Implicated in erythrokeratodermia variabilis and mutilating palmoplantar keratoderma with periorificial keratotic plaques. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.